NOS2 and non-small cell lung carcinoma: In addition, NOS has been reported to be associated with resistance to cisplatin and 5-fluorouracil through Wnt signaling and family with sequence similarity 171, member B in non-small cell lung cancer, breast cancer, and leukemia [7,26,27]; but this is a report of drug resistance regulated by NOS2.